Table of Contents
Picture of health: Sweeping federal reform and an aging population will drive industry demand
Health & Medical Insurance in the US
Consistent increases in healthcare expenditure and medical cost inflation, as well as a sharp decline in the uninsured rate, have driven industry growth in recent years. Industry revenue is correlated with total health expenditure, as operators increase premiums to maintain profitability. Despite this revenue growth, medical cost increases and new legislation mandating minimum medical loss ratios have put pressure on industry profit. As a result, revenue is anticipated to increase over the five years to 2016, while profit margins are expected to decline slightly. Over the five years to 2021, revenue is forecast to rise. Other key sources of growth include medical cost inflation and increased demand from the aging US population.
This industry underwrites (i.e. assumes the risks of and assigns premiums for) health and medical insurance policies. Insurance is the transfer of the risk of a loss in exchange for payment. Operators also provide administrative services for self-funded insurance plans (whereby an employer provides health benefits to workers with its own funds). Under this structure, the industry operator is a third-party administrator and is not responsible for health benefit payments.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Reinsurance Carriers in the US
Health & Welfare Funds in the US
Workers' Compensation & Other Insurance Funds in the US
Emergency & Other Outpatient Care Centers in the US
Global Life & Health Insurance Carriers
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The global veterinary diagnostics market is estimated to grow at a CAGR of 9.3% from 2017 to 2022, to reach USD 3.62 billion by 2022 from USD 2.31 billion in 2017. The growth of this market is mainly ...
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Many countries are facing the challenge ...
Use this report to: - Gain insight into bionics industry, major types of bionics device and rapidly evolving technologies. - Identify key market dynamics and the factors that may influence the long-term ...